Evaluate Safety, Tolerability and PK of HLX55 in Patients With Advanced Solid Tumors With Different cMET Status

NCT04169178 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

DRUG: HLX55

Sponsor

Henlix, Inc